22/12/2014 21:16:14 Free Membership Login

Biota Pharmaceuticals News (NASDAQ:BOTA)

DateTimeSource
Headline
08/01/20149:38AMBWBIOTA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Biota Pharmaceuticals, Inc.
Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Biota Pharmaceuticals, Inc, (Nasdaq: BOTA) violated state or federal laws. Biota Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of anti-infective... More...>>
08/01/20147:00AMGLOBEBiota Reports Top-Line Data From Its Phase 2 "IGLOO" Trial of Laninamivir Octanoate
ATLANTA, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced top-line data from a randomized, double-blind, placebo-controlled, parallel-arm Phase 2 clinical trial comparing the safety and efficacy of a 40 mg and 80 mg dose of laninamivir octanoate ("LANI") to placebo... More...>>
06/02/20146:00AMGLOBEBiota Announces Restructuring Plan
ATLANTA, June 2, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced that following the completion of an operational review of the Company, its Board of Directors has adopted a plan to restructure the Company's operations. The adoption of the plan was the result of a recent... More...>>
05/28/20149:58AMGLOBEBiota to Present at the Jefferies 2014 Global Healthcare Conference
ATLANTA, May 28, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced that its Executive Vice President, Dr. Joseph Patti, will present a corporate update at the Jefferies 2014 Global Healthcare Conference on Monday, June 2nd at 8:00 AM ET at The Grand Hyatt Hotel in New York... More...>>
05/12/20144:42PMPRNUS34% Drop in Biota Pharmaceutical, Inc.'s Stock Price: Law Firm Investigates on Behalf of Shareholders
34% Drop in Biota Pharmaceutical, Inc.'s Stock Price: Law Firm Investigates on Behalf of Shareholders PR Newswire SAN DIEGO and NEW YORK, May 12, 2014 SAN DIEGO and NEW YORK, May 12, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating potential violations of federal securities laws on... More...>>
05/09/20149:42PMPRNUSFaruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Biota Pharmaceuticals, Inc. (BOTA) To ...
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Biota Pharmaceuticals, Inc. (BOTA) To Contact The Firm PR Newswire NEW YORK, May 9, 2014 NEW YORK, May 9, 2014 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities... More...>>
05/08/20147:00AMGLOBEBiota Provides Update on BARDA Contract for Laninamivir Octanoate
ATLANTA, May 8, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced that last night it received notice from the Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response (ASPR) Biomedical Advanced Research and Development Authority... More...>>
05/06/20144:08PMGLOBEBiota Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent Corporate Developments
ATLANTA, May 6, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced its financial results for the three month and nine month periods ended March 31, 2014, and provided an update on recent corporate developments. "We are pleased with the significant improvement in our operating... More...>>
04/30/201410:00PMGLOBEBiota Provides an Update on the Development of Laninamivir Octanoate
ATLANTA, April 30, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced that an interim update has been provided from the U.S. Department of Health and Human Services (HHS) and the Biomedical Advanced Research and Development Authority (BARDA) with respect to the Stop-Work... More...>>
04/29/201412:20PMPRNUSSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biota Pharmaceuticals, Inc. - BOTA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biota Pharmaceuticals, Inc. - BOTA PR Newswire NEW YORK, April 29, 2014 NEW YORK, April 29, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biota Pharmaceuticals, Inc. ("Biota" or the "Company") (NASDAQ:... More...>>
04/29/20147:00AMGLOBEBiota Provides an Update on the Development of Laninamivir Octanoate
- Stop-Work Order Received Pending In Process Review Decision From BARDA - - Phase 2 IGLOO Top-Line Data Anticipated in Q3 2014 - ATLANTA, April 29, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ( the "Company") today announced that it has been notified by the U.S. Department of Health and Human Services... More...>>
04/29/20146:00AMGLOBEBiota Pharmaceuticals, Inc. Announces Upcoming Events
Management to Host Conference Call to Review Q3 Financial Results Management to Present at Deutsche Bank 39th Annual Health Care Conference ATLANTA, April 29, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company") announced today that management will host a conference call on Tuesday... More...>>
02/24/20144:33PMGLOBEBiota Pharmaceuticals, Inc. to Present at the 26th Annual ROTH Conference
ATLANTA, Feb. 24, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) today announced that its President and Chief Executive Officer, Russell H. Plumb, will present an update on the company at the 26th Annual ROTH Conference at 12:30 p.m. PDT, March 11, 2014, at The Ritz-Carlton, Dana Point in California... More...>>
02/10/20147:00AMGLOBEBiota Pharmaceuticals Reports Second Quarter 2013 Financial Results and Recent Corporate Developments
ATLANTA, Feb. 10, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced its financial results for the three month and six month periods ended December 31, 2013, and provided an update on recent corporate developments. "Our financial results and lower overhead expenses for the... More...>>
02/03/20149:00AMGLOBEBiota Pharmaceuticals to Host Conference Call to Report Second Quarter Financial Results on February 10, 2014
ATLANTA, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company") announced today that management will host a conference call on Monday, February 10, 2014 at 9:00a.m EST to review the Company's second quarter financial results and provide an update on recent corporate developments... More...>>
01/14/20147:00AMGLOBEBiota Announces Full Exercise of Over-Allotment Option
ATLANTA, Jan. 14, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company") today announced that Guggenheim Securities, LLC has exercised its option to purchase an additional 872,085 common shares to cover over-allotments in connection with the Company's public offering of its common... More...>>
01/10/20148:30AMGLOBEBiota Prices $25 Million Public Offering
ATLANTA, Jan. 10, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company") today announced that it has priced a public offering of 5,813,900 shares of its common stock at a purchase price of $4.30 per share for an aggregate offering amount of approximately $25 million. The net proceeds... More...>>
01/09/20144:01PMGLOBEBiota Announces Proposed Public Offering
ATLANTA, Jan. 9, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company") today announced its intention, subject to market and other conditions, to commence a public offering of its common stock. The Company intends to use the net proceeds from the offering for working capital... More...>>
12/23/20136:29AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to actively trade in Monday's session are Archer Daniels Midland Co. (ADM), Biota Pharmaceuticals Inc. (BOTA) and Hologic Inc. (HOLX). Archer Daniels Midland has agreed to pay more than $36 million to settle charges under the Foreign Corrupt Practices Act that it failed to prevent... More...>>
12/20/20134:49PMGLOBEBiota Reports That Laninamivir Octanoate is Approved for the Prevention of Influenza in Japan
ATLANTA, Dec. 20, 2013 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company") today reported that Daiichi Sankyo Company, Limited ("Daiichi Sankyo") has been granted regulatory approval in Japan to manufacture and market Inavir® Dry Powder Inhaler 20mg (generic name laninamivir octanoate... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq bota141222 21:16